Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scientists test intravenous psychedelic in healthy volunteers to map its effects

NCT ID NCT07444788

Recruiting now Knowledge-focused Sponsor: University Hospital, Basel, Switzerland Source: ClinicalTrials.gov ↗

First seen Mar 06, 2026 · Last updated Apr 30, 2026 · Updated 7 times

Summary

This study gives healthy adults a single intravenous dose of 5-MeO-DMT (a fast-acting psychedelic) or a placebo to measure its short-term effects on mood, heart rate, and blood levels. Participants are randomly assigned and don't know which they receive. The goal is to understand safety and how the drug works in the body, not to treat any disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for 5-METHOXY-DIMETHYLTRYPTAMINE (5-MEO-DMT) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospital Basel

    RECRUITING

    Basel, Canton of Basel-City, 4056, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

5-METHOXY-DIMETHYLTRYPTAMINE (5-MEO-DMT)